These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 19129156)
1. A hybrid cohort individual sampling natural history model of age-related macular degeneration: assessing the cost-effectiveness of screening using probabilistic calibration. Karnon J; Czoski-Murray C; Smith KJ; Brand C Med Decis Making; 2009; 29(3):304-16. PubMed ID: 19129156 [TBL] [Abstract][Full Text] [Related]
2. A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration. Karnon J; Czoski-Murray C; Smith K; Brand C; Chakravarthy U; Davis S; Bansback N; Beverley C; Bird A; Harding S; Chisholm I; Yang YC Health Technol Assess; 2008 Jun; 12(27):iii-iv, ix-124. PubMed ID: 18513468 [TBL] [Abstract][Full Text] [Related]
3. Computerized model of cost-utility analysis for treatment of age-related macular degeneration. Fletcher EC; Lade RJ; Adewoyin T; Chong NV Ophthalmology; 2008 Dec; 115(12):2192-8. PubMed ID: 18930556 [TBL] [Abstract][Full Text] [Related]
4. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration. Shah AR; Del Priore LV Ophthalmology; 2009 Oct; 116(10):1901-7. PubMed ID: 19592101 [TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of treatment of age-related macular degeneration: a review. Kymes Steven M Minerva Med; 2009 Feb; 100(1):69-78. PubMed ID: 19277005 [TBL] [Abstract][Full Text] [Related]
6. Reliability, normative data, and the effect of age-related macular disease on the Eger Macular Stressometer photostress recovery time. Bartlett H; Davies LN; Eperjesi F Ophthalmic Physiol Opt; 2004 Nov; 24(6):594-9. PubMed ID: 15491488 [TBL] [Abstract][Full Text] [Related]
8. The epidemiology of age-related macular degeneration in the Indian subcontinent. Woo JH; Sanjay S; Au Eong KG Acta Ophthalmol; 2009 May; 87(3):262-9. PubMed ID: 19016663 [TBL] [Abstract][Full Text] [Related]
9. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population. Janik-Papis K; Zaras M; Krzyzanowska A; Wozniak K; Blasiak J; Szaflik J; Szaflik JP Exp Mol Pathol; 2009 Dec; 87(3):234-8. PubMed ID: 19761764 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group. ; Solomon SD; Jefferys JL; Hawkins BS; Bressler NM; Bressler SB Retina; 2009 Sep; 29(8):1080-90. PubMed ID: 19734762 [TBL] [Abstract][Full Text] [Related]
12. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292 [TBL] [Abstract][Full Text] [Related]
13. Age-related macular degeneration in Singapore. Cheng CL; Saw SM; Pang CE; Chee C Singapore Med J; 2009 Feb; 50(2):126-31. PubMed ID: 19296026 [TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730 [TBL] [Abstract][Full Text] [Related]
15. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions. Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H Retina; 2009; 29(7):960-5. PubMed ID: 19491727 [TBL] [Abstract][Full Text] [Related]
16. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study. Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969 [TBL] [Abstract][Full Text] [Related]
17. DNA damage and repair in age-related macular degeneration. Szaflik JP; Janik-Papis K; Synowiec E; Ksiazek D; Zaras M; Wozniak K; Szaflik J; Blasiak J Mutat Res; 2009 Oct; 669(1-2):169-76. PubMed ID: 19559717 [TBL] [Abstract][Full Text] [Related]
18. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting. Cohen SY; Dubois L; Tadayoni R; Fajnkuchen F; Nghiem-Buffet S; Delahaye-Mazza C; Guiberteau B; Quentel G Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. Scheetz MH; Bolon MK; Postelnick M; Noskin GA; Lee TA J Antimicrob Chemother; 2009 Apr; 63(4):816-25. PubMed ID: 19202150 [TBL] [Abstract][Full Text] [Related]
20. Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants. Hopley C; Salkeld G; Wang JJ; Mitchell P Br J Ophthalmol; 2004 Apr; 88(4):450-4. PubMed ID: 15031152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]